{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:56:53Z","timestamp":1768888613486,"version":"3.49.0"},"reference-count":36,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,4,1]]},"DOI":"10.1248\/bpb.b25-00016","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T22:19:52Z","timestamp":1743459592000},"page":"337-343","source":"Crossref","is-referenced-by-count":2,"title":["Safety Assessment of Medications during Pregnancy and Breastfeeding Based on Quantitative and Toxicological Analyses"],"prefix":"10.1248","volume":"48","author":[{"given":"Ayako","family":"Furugen","sequence":"first","affiliation":[{"name":"Division of Healthcare Innovation in Pharmacy, Faculty of Pharmacy, Keio University, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"},{"name":"Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060\u20130812, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nishigori H, Obara T, Nishigori T, Metoki H, Ishikuro M, Mizuno S, Sakurai K, Tatsuta N, Nishijima I, Fujiwara I, Arima T, Nakai K, Mano N, Kuriyama S, Yaegashi N. Drug use before and during pregnancy in Japan: the Japan environment and children\u2019s study. Pharmacy<\/i> (Basel), 5<\/b>, 21 (2017).","DOI":"10.3390\/pharmacy5020021"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fujii Y, Hirokawa K, Kobuke Y, Kubota T, Yoshitake T, Haraguchi K, Honda Y, Kobayashi H, Harada KH. Use of nonprescription and prescription drugs and drug information sources among breastfeeding women in Japan: a cross-sectional study. Int. J. Environ. Res. Public Health<\/i>, 19<\/b>, 11722 (2022).","DOI":"10.3390\/ijerph191811722"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ji L, Brki\u0107 J, Liu M, Fu G, Peng C, Wang YL. Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. Mol. Aspects Med.<\/i>, 34<\/b>, 981\u20131023 (2013).","DOI":"10.1016\/j.mam.2012.12.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tetro N, Moushaev S, Rubinchik-Stern M, Eyal S. The placental barrier: the gate and the fate in drug distribution. Pharm. Res.<\/i>, 35<\/b>, 71 (2018).","DOI":"10.1007\/s11095-017-2286-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Avachat C, Barry JM, Lyu X, Sherwin CM, Birnbaum AK. Management of anti-seizure medications during pregnancy: advancements in the past decade. Pharmaceutics<\/i>, 14<\/b>, 2733 (2022).","DOI":"10.3390\/pharmaceutics14122733"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol.<\/i>, 10<\/b>, 609\u2013617 (2011).","DOI":"10.1016\/S1474-4422(11)70107-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Herzog AG, Mandle HB, Cahill KE, Fowler KM, Hauser WA. Predictors of unintended pregnancy in women with epilepsy. Neurology<\/i>, 88<\/b>, 728\u2013733 (2017).","DOI":"10.1212\/WNL.0000000000003637"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Furugen A, Kobayashi M, Nishimura A, Takamura S, Narumi K, Yamada T, Iseki K. Quantification of new antiepileptic drugs by liquid chromatography\/electrospray ionization tandem mass spectrometry and its application to cellular uptake experiment using human placental choriocarcinoma BeWo cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/i>, 1002<\/b>, 228\u2013233 (2015).","DOI":"10.1016\/j.jchromb.2015.08.031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Furugen A, Ishiguro Y, Kobayashi M, Narumi K, Nishimura A, Hirano T, Iseki K. Involvement of l-type amino acid transporter 1 in the transport of gabapentin into human placental choriocarcinoma cells. Reprod. Toxicol.<\/i>, 67<\/b>, 48\u201355 (2017).","DOI":"10.1016\/j.reprotox.2016.11.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hasegawa N, Furugen A, Ono K, Koishikawa M, Miyazawa Y, Nishimura A, Umazume T, Narumi K, Kobayashi M, Iseki K. Cellular uptake properties of lamotrigine in human placental cell lines: investigation of involvement of organic cation transporters (SLC22A1-5<\/i>). Drug Metab. Pharmacokinet.<\/i>, 35<\/b>, 266\u2013273 (2020).","DOI":"10.1016\/j.dmpk.2020.01.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ono K, Furugen A, Kurosawa Y, Jinno N, Narumi K, Kobayashi M, Iseki K. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: induction of xCT\/SLC7A11 in human placental BeWo cells. Placenta<\/i>, 75<\/b>, 34\u201341 (2019).","DOI":"10.1016\/j.placenta.2018.11.010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Koishikawa M, Furugen A, Ohyama N, Narumi K, Ishikawa S, Kobayashi M. Uptake of antiepileptic drugs in forskolin-induced differentiated BeWo cells: alteration of gabapentin transport. Xenobiotica<\/i>, 52<\/b>, 405\u2013412 (2022).","DOI":"10.1080\/00498254.2022.2085635"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kurosawa Y, Furugen A, Nishimura A, Narumi K, Kobayashi M, Iseki K. Evaluation of the effects of antiepileptic drugs on folic acid uptake by human placental choriocarcinoma cells. Toxicol. In Vitro<\/i>, 48<\/b>, 104\u2013110 (2018).","DOI":"10.1016\/j.tiv.2017.12.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Miyazawa Y, Furugen A, Aoyagi R, Kosugi H, Nishimura A, Umazume T, Narumi K, Kobayashi M. Kobayashi M. Alteration in folate carrier expression via histone deacetylase inhibition in BeWo human placental choriocarcinoma cells. Toxicol. In Vitro<\/i>, 101<\/b>, 105934 (2024).","DOI":"10.1016\/j.tiv.2024.105934"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol.<\/i>, 12<\/b>, 244\u2013252 (2013).","DOI":"10.1016\/S1474-4422(12)70323-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Christensen J, Gr\u00f8nborg TK, S\u00f8rensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA<\/i>, 309<\/b>, 1696\u20131703 (2013).","DOI":"10.1001\/jama.2013.2270"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Furugen A, Kanno Y, Ohyama N, Kurosawa Y, Jinno N, Narumi K, Iseki K, Kobayashi M. Effects of valproate, an HDAC inhibitor, on the expression of folate carriers and folate metabolism-related genes in the placenta of rats. Drug Metab. Pharmacokinet.<\/i>, 40<\/b>, 100409 (2021).","DOI":"10.1016\/j.dmpk.2021.100409"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jinno N, Furugen A, Kurosawa Y, Kanno Y, Narumi K, Kobayashi M, Iseki K. Effects of single and repetitive valproic acid administration on the gene expression of placental transporters in pregnant rats: an analysis by gestational period. Reprod. Toxicol.<\/i>, 96<\/b>, 47\u201356 (2020).","DOI":"10.1016\/j.reprotox.2020.04.077"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ohyama N, Furugen A, Sawada R, Aoyagi R, Nishimura A, Umazume T, Narumi K, Kobayashi M. Effects of valproic acid on syncytialization in human placental trophoblast cell lines. Toxicol. Appl. Pharmacol.<\/i>, 474<\/b>, 116611 (2023).","DOI":"10.1016\/j.taap.2023.116611"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Victora CG, Bahl R, Barros AJ, Fran\u00e7a GV, Horton S, Krasevec J, Murch S, Sankar MJ, Walker N, Rollins NC. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet<\/i>, 387<\/b>, 475\u2013490 (2016).","DOI":"10.1016\/S0140-6736(15)01024-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mazer-Amirshahi M, Samiee-Zafarghandy S, Gray G, van den Anker JN. Trends in pregnancy labeling and data quality for US-approved pharmaceuticals. Am. J. Obstet. Gynecol.<\/i>, 211<\/b>, 690.e1\u2013690.e11 (2014).","DOI":"10.1016\/j.ajog.2014.06.013"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Anderson PO, Sauberan JB. Modeling drug passage into human milk. Clin. Pharmacol. Ther.<\/i>, 100<\/b>, 42\u201352 (2016).","DOI":"10.1002\/cpt.377"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr. Clin. North Am.<\/i>, 60<\/b>, 49\u201374 (2013).","DOI":"10.1016\/j.pcl.2012.10.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Delplanque B, Gibson R, Koletzko B, Lapillonne A, Strandvik B. Lipid quality in infant nutrition: current knowledge and future opportunities. J. Pediatr. Gastroenterol. Nutr.<\/i>, 61<\/b>, 8\u201317 (2015).","DOI":"10.1097\/MPG.0000000000000818"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Furey A, Moriarty M, Bane V, Kinsella B, Lehane M. Ion suppression; a critical review on causes, evaluation, prevention and applications. Talanta<\/i>, 115<\/b>, 104\u2013122 (2013).","DOI":"10.1016\/j.talanta.2013.03.048"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Furugen A, Nishimura A, Kobayashi M, Umazume T, Narumi K, Iseki K. Quantification of eight benzodiazepines in human breastmilk and plasma by liquid\u2013liquid extraction and liquid-chromatography tandem mass spectrometry: application to evaluation of alprazolam transfer into breastmilk. J. Pharm. Biomed. Anal.<\/i>, 168<\/b>, 83\u201393 (2019).","DOI":"10.1016\/j.jpba.2019.02.011"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nishimura A, Furugen A, Umazume T, Kitamura S, Soma M, Noshiro K, Takekuma Y, Sugawara M, Iseki K, Kobayashi M. Benzodiazepine concentrations in the breast milk and plasma of nursing mothers: estimation of relative infant dose. Breastfeed. Med.<\/i>, 16<\/b>, 424\u2013431 (2021).","DOI":"10.1089\/bfm.2020.0259"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Furugen A, Nishimura A, Umazume T, Ishikawa H, Narumi K, Kobayashi M. Simple and validated method to quantify lacosamide in human breast milk and plasma using UPLC\/MS\/MS and its application to estimate drug transfer into breast milk. J. Pharm. Health Care Sci.<\/i>, 9<\/b>, 26 (2023).","DOI":"10.1186\/s40780-023-00295-w"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Tamaki R, Noshiro K, Furugen A, Nishimura A, Asano H, Watari H, Kobayashi M, Umazume T. Breast milk concentrations of acetaminophen and diclofenac\u2014unexpectedly high mammary transfer of the general-purpose drug acetaminophen. BMC Pregnancy Childbirth<\/i>, 24<\/b>, 90 (2024).","DOI":"10.1186\/s12884-024-06287-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ishikawa H, Furugen A, Nishimura A, Umazume T, Ishikawa S, Aoyagi R, Narumi K, Okamoto K, Takekuma Y, Sugawara M, Kobayashi M. Validated UPLC-MS\/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: application to quantify suvorexant and lemborexant in clinical samples. J. Pharm. Biomed. Anal.<\/i>, 251<\/b>, 116432 (2024).","DOI":"10.1016\/j.jpba.2024.116432"},{"key":"31","unstructured":"31) Einarson A, Selby P, Koren G. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J. Psychiatry Neurosci.<\/i>, 26<\/b>, 44\u201348 (2001)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ. Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br. J. Clin. Pharmacol.<\/i>, 40<\/b>, 231\u2013236 (1995).","DOI":"10.1111\/j.1365-2125.1995.tb05778.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Okuda S, Qureshi ZP, Yanagida Y, Ito C, Homma Y, Tokita S. Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database. BMC Psychiatry<\/i>, 23<\/b>, 278 (2023).","DOI":"10.1186\/s12888-023-04683-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Rawal S, Brimhall D, Aluri J, Cheng JY, Hall N, Moline M. Lemborexant levels in breast milk after single doses in healthy, lactating women. Br. J. Clin. Pharmacol.<\/i>, 90<\/b>, 158\u2013163 (2024).","DOI":"10.1111\/bcp.15880"},{"key":"35","unstructured":"35) Food and Drug Administration. \u201cHIGHLIGHTS OF PRESCRIBING INFORMATION. BELSOMRA\u00ae _(suvorexant) tablets, for oral use Initial U.S. Approval: 2014, Revised: 7\/2018.\u201d: <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/204569s005lbl.pdf>, accessed 29 December, 2024."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ito N, Ito K, Koshimichi H, Hisaka A, Honma M, Igarashi T, Suzuki H. Contribution of protein binding, lipid partitioning, and asymmetrical transport to drug transfer into milk in mouse versus<\/i> human. Pharm. Res.<\/i>, 30<\/b>, 2410\u20132422 (2013).","DOI":"10.1007\/s11095-013-1085-5"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/4\/48_b25-00016\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T03:50:48Z","timestamp":1743825048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/4\/48_b25-00016\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00016","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"b25-00016"}}